S
Stig Holmberg
Researcher at Sahlgrenska University Hospital
Publications - 149
Citations - 9445
Stig Holmberg is an academic researcher from Sahlgrenska University Hospital. The author has contributed to research in topics: Cardiopulmonary resuscitation & Ventricular fibrillation. The author has an hindex of 48, co-authored 149 publications receiving 9041 citations. Previous affiliations of Stig Holmberg include University of Gothenburg & Malmö University.
Papers
More filters
Journal ArticleDOI
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.
Å Hjalmarson,Johan Herlitz,I Málek,Lars Rydén,Anders Vedin,Ann-Charlotte Waldenström,Hans Wedel,Dag Elmfeldt,Stig Holmberg,G Nyberg,Karl Swedberg,Finn Waagstein,J Waldenström,Lars Wilhelmsen,Claes Wilhelmsson +14 more
TL;DR: The effect of metoprolol on mortality was compared with that of placebo in a double blind randomised trial in patients with definite or suspected acute myocardial infarction and there was a reduction of 36% (p less than 0.03).
Journal ArticleDOI
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R. C. Coombes,Lucy Kilburn,Claire Snowdon,Robert Paridaens,Robert E. Coleman,Stephen E. Jones,Jacek Jassem,Cjh van de Velde,Thierry Delozier,Isabel Alvarez,L. Del Mastro,Olaf Ortmann,K Diedrich,Alan S. Coates,Emilio Bajetta,Stig Holmberg,D. Dodwell,Elizabeth Mickiewicz,Jens O. Andersen,Per Eystein Lønning,G. Cocconi,John F. Forbes,Monica Castiglione,N Stuart,Alan L Stewart,Lesley Fallowfield,Gianfilippo Bertelli,Emma Hall,R. G. Bogle,M. Carpentieri,E Colajori,M Subar,E. Ireland,Judith M Bliss +33 more
TL;DR: The results suggest that early improvements in disease-free survival noted in patients who switch to exemestane after 2-3 years on tamoxifen persist after treatment, and translate into a modest improvement in overall survival.
Journal ArticleDOI
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
Bernhard C. Pestalozzi,David Zahrieh,Karen N. Price,Stig Holmberg,J. Lindtner,John P. Collins,Diana Crivellari,Martin F. Fey,Elizabeth Murray,Olivia Pagani,Edda Simoncini,Monica Castiglione-Gertsch,Richard D. Gelber,Alan S. Coates,A. Goldhirsch +14 more
TL;DR: Using data from 9524 women with early breast cancer who were randomized in International Breast Cancer Study Group clinical trials between 1978 and 1999, a group at sufficient risk to justify routine screening for occult central nervous system metastases was not defined.
Journal ArticleDOI
Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials
Bernhard C. Pestalozzi,David Zahrieh,Elizabeth Mallon,Barry A. Gusterson,Karen N. Price,Richard D. Gelber,Stig Holmberg,Jurij Lindtner,Raymond Snyder,Beat Thürlimann,Elizabeth Murray,Giuseppe Viale,Monica Castiglione-Gertsch,Alan S. Coates,Aron Goldhirsch +14 more
TL;DR: ILC is more than a histologic variant of breast cancer, and the diagnosis of ILC carries distinct prognostic and biologic implications.
Journal ArticleDOI
Effect of Bystander Cardiopulmonary Resuscitation in Out-Of-Hospital Cardiac Arrest Patients in Sweden
TL;DR: In Sweden, the willingness and ability to perform B-CPR appears to be relatively widespread and two to threefold increase in survival is reported, which is in contrast to cardiac arrest in other places where 53% were given CPR.